It should be noted that the majority of the samples in this data set came from patients with stage 4 cancer (n = 81 of 140), suggesting that the prognostic value of ESR1 expression as a marker of LSCC aggression may exist independent of any association with late-stage cancer. Here, ESR1 is linked to cancer.